Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia

We report a preliminary experience of adjuvant therapy with Hemoperfusion (HP) in patients with Severe Acute Respiratory Syndrome-CoronaVirus 2 (SARS-CoV2) pneumonia. Currently, there are no approved treatments for CoronaVirus Disease 19 (COVID-19); however, therapeutic strategies based on the precl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Purif
Autors principals: Rampino, Teresa, Gregorini, Marilena, Perotti, Luciano, Ferrari, Fiorenza, Pattonieri, Eleonora Francesca, Grignano, Maria Antonietta, Valente, Mauro, Garrone, Alberto, Islam, Tefik, Libetta, Carmelo, Sepe, Vincenzo, Albertini, Riccardo, Bruno, Raffaele, Belliato, Mirko
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705939/
https://ncbi.nlm.nih.gov/pubmed/33181508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000511725
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars